Evidence map›Paper›PMID 35720499›Full record

ArticleOncology letters2022

Significant accumulation of

Toshiaki Kataoka, Koji Okudela, Mai Matsumura, Tomohisa Baba, Hideya Kitamura, Hiromasa Arai, Takeshisa Suzuki, Chihiro Koike, Hideaki Mutsui, Motoki Sekiya and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Cancers · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Toshiaki KataokaDepartment of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Koji OkudelaDepartment of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Mai MatsumuraDepartment of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Tomohisa BabaDivision of Respirology, Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital, Yokohama, Kanagawa 236-0051, Japan.
Hideya KitamuraDivision of Respirology, Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital, Yokohama, Kanagawa 236-0051, Japan.
Hiromasa AraiDivision of Surgery, Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital, Yokohama, Kanagawa 236-0051, Japan.
Takeshisa SuzukiDepartment of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Chihiro KoikeDepartment of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Hideaki MutsuiDepartment of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Motoki SekiyaDivision of Pathology, Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital, Yokohama, Kanagawa 236-0051, Japan.
Misaki SugiyamaDivision of Pathology, Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital, Yokohama, Kanagawa 236-0051, Japan.
Tamiko TakemuraDivision of Pathology, Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital, Yokohama, Kanagawa 236-0051, Japan.
Tae IwasawaDivision of Radiology, Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital, Yokohama, Kanagawa 236-0051, Japan.
Takashi OguraDivision of Respirology, Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital, Yokohama, Kanagawa 236-0051, Japan.
Kenichi OhashiDepartment of Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa 236-0004, Japan.
Kanagawa Cardiovascular and Respiratory Center · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interstitial pneumonia (IP) is a major risk factor for lung adenocarcinoma (LADC). IP-related LADC predominantly develops in the bronchiolar metaplasia lining in honeycomb lesions. Kirsten rat sarcoma virus (

Indexed as

adenocarcinomabronchiolar metaplasiacarcinogenesisinterstitial pneumoniaKRASlung

Identifiers

PMID35720499
PMCPMC9185152
OpenAlexW4281607187

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.